The CYLD gene helps control signals that tell cells when to grow, especially in the skin and nearby tissues. If it does not work properly, people may develop multiple usually noncancerous skin growths such as cylindromas, spiradenomas, or trichoepitheliomas, often starting in adulthood. This inherited condition is called CYLD cutaneous syndrome. Many variants in this gene have little effect, while a pathogenic variant can confirm the diagnosis in an affected family.
What is a gene?
Genes are sections of DNA that give your cells instructions for making molecules or regulating activities in the body. Some genes carry the information needed to produce proteins, which do much of the work inside cells. Others mainly control when certain processes happen, where they take place, and how strongly they are carried out. Taken together, genes affect how the body develops and works, and they can influence how you respond to food, stress, or medications. For a deeper look at this topic, you can read more in the LearnHub.
Overview
CYLDGene function
What if the gene works
The CYLD gene helps keep cell growth and inflammatory signaling under control by removing small protein tags from certain cell proteins. This supports normal skin, nerve, and other tissue function.
Risk
What if the gene does not work
When the CYLD gene does not work properly, inherited skin tumor conditions can develop, often with benign growths on the scalp, face, and neck. Milder and more severe variants can influence how early these appear and how many develop.
Treatment
What does that mean for your treatment
With a pathogenic or loss-of-function variant in the CYLD gene, no CYLD-specific treatment or drug strategy is currently established. The CYLD gene is being studied as a tumor suppressor and possible biomarker in skin and other cancers, but this has not yet changed routine drug choices.
Conditions associated with CYLD
Gene function
What if the gene works
Your cells use the CYLD gene to keep growth and signaling in balance. Its protein removes small protein tags from selected proteins, which helps switch signals down after they have done their job. This is a central part of how the CYLD gene works in the body, especially for immune activity, cell growth, and routine cell upkeep.
One of the main jobs of the CYLD gene is to remove ubiquitin (small protein labels) from certain proteins. This helps cells reset signals once they are no longer needed.
By trimming these labels from key signal proteins, the CYLD gene helps turn major communication pathways down at the right time. This keeps cell messages measured rather than prolonged.
Many immune signals need to rise and fall in a controlled way. The CYLD gene helps cells fine tune these responses so inflammation stays appropriately regulated during everyday cell activity.
Cells constantly receive cues to grow, divide, pause, or wind down. The CYLD gene helps keep these instructions coordinated, supporting orderly tissue renewal and normal cell behavior.
What is a variant?
A genetic variant is a minor difference in the DNA sequence of a gene. These differences are common and help shape normal human diversity, including variation in appearance, metabolism, and how the body responds to environmental influences. Many variants do not cause any noticeable effect and are simply part of natural genetic variation. In some cases, though, a variant can change how a gene works more substantially and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the CYLD gene often make the CYLD protein shorter, unstable, or less able to remove ubiquitin (small control tags) from other proteins, leaving cell growth signals less tightly controlled. How CYLD gene variants affect protein function can range from a mild drop in activity to near complete loss, depending on the DNA change. Variants that leave less function are often linked to earlier symptoms or more numerous skin tumors in CYLD cutaneous syndrome.
How variants are linked to conditions
Pathogenic variants in the CYLD gene cause CYLD cutaneous syndrome, a group of inherited conditions that includes familial cylindromatosis, Brooke-Spiegler syndrome, and multiple familial trichoepithelioma. People with this diagnosis often develop multiple benign skin tumors, usually on the scalp, face, or neck. These growths may increase over time and can affect comfort, appearance, or hearing if they develop near the ear. This overview covers the conditions linked to CYLD gene variants.
A variant is not necessarily a diagnosis
Genetic variants are common across the general population and are a normal feature of human biology. Most do not directly affect health and instead reflect natural differences among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental factors also play a role. Still, in some situations, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
For inherited CYLD-related skin tumor conditions, risk is driven mainly by the gene change itself and family history. There is not enough evidence to say that specific lifestyle changes lower the chance of developing these growths. What can still help is regular skin checks and early treatment to limit problems as new lumps appear.
Inheritance of CYLD variants
CYLD-related conditions are usually inherited in an autosomal dominant pattern. This means a parent with a disease-causing variant in the CYLD gene can pass it to a child with a 50% chance in each pregnancy, whether the child is a boy or a girl. In practical terms, this is how CYLD gene variants are inherited in most families affected by CYLD cutaneous syndrome, including Brooke-Spiegler syndrome and related skin growth conditions. A person only needs one altered copy of the CYLD gene to inherit the condition.
What does my CYLD result mean for my family?
A disease-causing change in the CYLD gene is usually passed down in families in a dominant pattern, so close relatives such as parents, brothers, sisters, and children may also carry the same result. For many families, this means relatives may have a higher chance of developing similar skin growths over time, even if symptoms differ from one person to another. Family members may want to discuss the result and whether testing would be helpful for them.
Genetic information
Genetic testing
How you find out about variants
To find variants in the CYLD gene, CYLD genetic testing for inherited skin tumor conditions usually examines DNA from a blood or saliva sample. A lab reads the gene’s sequence and checks for changes linked with conditions such as CYLD cutaneous syndrome. Results may identify a pathogenic variant, no relevant variant, or a variant of uncertain significance.
When should I consider getting a genetic test?
Consider CYLD testing if you or close relatives have developed many repeated, usually noncancerous skin growths, especially on the scalp or face. A result can help confirm an inherited CYLD-related condition and clarify whether other family members may also carry the same gene change.
A genetic result is only one part of your health story
Genetic findings can offer valuable insight, but how much they explain varies based on the condition and the specific type of variant. Over time, many other factors also shape how the body works, including lifestyle, environment, age, and medical history. In some conditions, especially those influenced by many genes, genetic information provides context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can also help put personal experiences into perspective.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how your body responds to medicines. Small differences in genes can change how a drug is absorbed, broken down, moved through the body, or how strongly it acts on its target, so the same treatment may work differently from one person to another. This is common and can influence how well a medicine helps, whether side effects are more likely, or how sensitive someone is to a usual dose.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect a person’s response to medicines. It studies connections between genes and drugs to better understand why the same treatment may work differently from one person to another. For many medications, genes can influence both how strongly a drug works and how the body handles it. This knowledge can support more informed and more individualized treatment decisions. More detail on this topic is available in the LearnHub.
Drugs influenced by the CYLD gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in guiding medication choice or dose. General health concerns, new symptoms, or questions about side effects and medicines are best discussed with your doctor.
History
CYLD entered medical genetics through the study of families with unusual skin growths that passed from one generation to the next. In the late 1990s, researchers traced these inherited conditions to a region on chromosome 16 and then identified the CYLD gene itself. Initially understood only through visible traits, later recognized as tied to a specific gene, these conditions included familial cylindromatosis and Brooke-Spiegler syndrome. From these first observations, research expanded steadily, and doctors came to see that several syndromes once listed separately were closely related. This work helped connect long observed family patterns with a clear genetic cause and shaped modern classification of these inherited skin conditions.